-
1.
公开(公告)号:US20230119714A1
公开(公告)日:2023-04-20
申请号:US17990979
申请日:2022-11-21
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
2.
公开(公告)号:US20230250115A1
公开(公告)日:2023-08-10
申请号:US18135265
申请日:2023-04-17
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
CPC分类号: C07F9/5728 , C07D209/16 , A61K9/2054 , A61K9/0053 , A61K47/36 , A61K47/38 , C07B2200/13
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
3.
公开(公告)号:US20210087212A1
公开(公告)日:2021-03-25
申请号:US17116739
申请日:2020-12-09
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
4.
公开(公告)号:US20240360162A1
公开(公告)日:2024-10-31
申请号:US18767494
申请日:2024-07-09
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
CPC分类号: C07F9/5728 , A61K9/0053 , A61K9/2054 , A61K47/36 , A61K47/38 , C07D209/16 , C07B2200/13
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
5.
公开(公告)号:US20240252521A1
公开(公告)日:2024-08-01
申请号:US18522440
申请日:2023-11-29
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS , Megan CROAL , Hans Åke ERIKSSON , George GOLDSMITH , Molly Tabitha HICKEY , Shaun HURLEY , Ekaterina MALIEVSKAIA , Lindsey MARWOOD , Drummond E-Wen Joe MCCULLOCH , Laurie Emma MEDHURST , Nathan POULSEN , Aslihan SELIMBEYOGLU , Anaïs SOULA , Amanda Tan SHUXIANG , Manon Cecile Elisabeth VERAART , Tobias Patrick WHELAN , Lars Christian WILDE , Stephen WRIGHT
IPC分类号: A61K31/675 , A61K9/00 , A61K9/20 , A61K9/48 , A61K31/661 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , C07F9/572
CPC分类号: A61K31/675 , A61K9/0053 , A61K9/20 , A61K9/48 , A61K31/661 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , C07F9/5728 , C07B2200/13
摘要: The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.
-
6.
公开(公告)号:US20240199660A1
公开(公告)日:2024-06-20
申请号:US18433051
申请日:2024-02-05
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
CPC分类号: C07F9/5728 , A61K9/0053 , A61K9/2054 , A61K47/36 , A61K47/38 , C07D209/16 , C07B2200/13
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
7.
公开(公告)号:US20230330117A1
公开(公告)日:2023-10-19
申请号:US18210526
申请日:2023-06-15
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS , Megan CROAL , Hans Åke ERIKSSON , George GOLDSMITH , Molly Tabitha HICKEY , Shaun HURLEY , Ekaterina MALIEVSKAIA , Lindsey MARWOOD , Drummond E-Wen Joe MCCULLOCH , Laurie Emma MEDHURST , Nathan POULSEN , Aslihan SELIMBEYOGLU , Anaïs SOULA , Amanda Tan SHUXIANG , Manon Cecile Elisabeth VERAART , Tobias Patrick WHELAN , Lars Christian WILDE , Stephen WRIGHT
IPC分类号: A61K31/675 , A61P25/00 , A61P25/20 , A61P25/28 , A61P25/22 , A61P25/04 , A61P25/08 , A61P25/16 , C07F9/572 , A61K9/00 , A61K9/20 , A61K9/48 , A61K31/661 , A61P25/24
CPC分类号: A61K31/675 , A61P25/00 , A61P25/20 , A61P25/28 , A61P25/22 , A61P25/04 , A61P25/08 , A61P25/16 , C07F9/5728 , A61K9/0053 , A61K9/20 , A61K9/48 , A61K31/661 , A61P25/24 , C07B2200/13
摘要: The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.
-
公开(公告)号:US20230023092A1
公开(公告)日:2023-01-26
申请号:US17604610
申请日:2020-04-17
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS , Megan CROAL , Hans Ake ERIKSSON , George GOLDSMITH , Molly Tabitha HICKEY , Shaun HURLEY , Ekaterina MALIEVSKAIA , Lindsey MARWOOD , Drummond E-Wen Joe MCCULLOCH , Laurie Emma MEDHURST , Nathan POULSEN , Aslihan SELIMBEYOGLU , Anais SOULA , Amanda Tan SHUXIANG , Manon Cecile Elisabeth VERAART , Tobias Patrick WHELAN , Lars Christian WILDE , Stephen WRIGHT
摘要: The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat depression, neurocognitive disorders, autism spectrum disorder, and/or attention-deficit/hyperactivity disorder.
-
9.
公开(公告)号:US20220088041A1
公开(公告)日:2022-03-24
申请号:US17540962
申请日:2021-12-02
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS , Megan CROAL , Hans Åke ERIKSSON , George GOLDSMITH , Molly Tabitha HICKEY , Shaun HURLEY , Ekaterina MALIEVSKAIA , Lindsey MARWOOD , Drummond E-Wen Joe MCCULLOCH , Laurie Emma MEDHURST , Nathan POULSEN , Aslihan SELIMBEYOGLU , Anaïs SOULA , Amanda Tan SHUXIANG , Manon Cecile Elisabeth VERAART , Tobias Patrick WHELAN , Lars Christian WILDE , Stephen WRIGHT
IPC分类号: A61K31/675 , A61P25/00
摘要: The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.
-
10.
公开(公告)号:US20220402949A1
公开(公告)日:2022-12-22
申请号:US17886204
申请日:2022-08-11
发明人: Derek John LONDESBROUGH , Christopher BROWN , Julian Scott NORTHEN , Gillian MOORE , Hemant Kashinath PATIL , David E. NICHOLS
摘要: This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
-
-
-
-
-
-
-
-
-